Patent · US Active

Method and immunoabsorbents for specific detection and absorption of antibodies associated with celiac disease and dermatitis herpetiformis

US8124354B2 · kind B2 · utility

0Cited by

0References

16Claims

0Family size

Assignee

EUROIMMUN Medizinische Labordiagnostika AG · DE

Inventors

Christian Probst · Herrnburg, DE
Wolfgang Schlumberger · Langenau, DE
Winfried Stöcker · Erkrath, DE
Cornelia Dähnrich · Langenau, DE
Lars Komorowski · Ratzeburg, DE
Thomas Mothes · Leipzig, DE

Key dates

Filing date	Apr 25, 2008
Grant date	Feb 28, 2012
Priority date	—
Expiry date	Oct 19, 2028

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/24
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The present invention relates to fusion peptides that are derived from components of gliadin, to a method and reagents for the serological diagnosis of celiac disease or dermatitis herpetiformis by way of assaying antibodies that are directed against modified gliadin. The invention also relates to methods and pharmaceutical compositions for treating said diseases by specific immunoabsorption of these antibodies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.